This article is for all providers caring for our members
As of January 15, 2022, we will cover up to eight self-administered at-home tests per commercial member per month for personal, diagnostic use, without cost and without any need for prior clinical assessment. We will also reimburse up to $12 per FDA-authorized, self-administered at-home test for up to four tests per month for Medicare Advantage members.
The coverage is not retroactive and will not apply to any test kit purchases made prior to January 15, 2022.
Eligible members can complete the COVID-19 At-Home Test Reimbursement form (PDF). Eligible Medicare Advantage members can complete the Medicare Advantage COVID-19 At-Home Test Reimbursement form (PDF).
For more information on the new policy, visit here for details.
Additionally, we will continue to cover FDA-authorized COVID diagnostic tests, such as PCR tests, with no cost share to members when ordered or administered by a health care provider following an individualized clinical assessment. This applies to our commercial and Medicare members.
For information regarding coverage for our FEP members, please visit www.fepblue.org/coronavirus-updates/over-the-counter-tests.
As of January 19, every household in the U.S. is also eligible to order up to four free, at-home COVID-19 tests from the federal government. People can order free tests here.